|
Ile76]-TNF-a (70-80) (human)
|
PRO-SER-THR-HIS-VAL-LEU-ILE-THR-HIS-THR-ILE
|
|
|
Biotin-Insulin Receptor (1142-1153)
|
BIOTIN-THR-ARG-ASP-ILE-TYR-GLU-THR-ASP-TYR-TYR-ARG-LYS
|
|
|
Biotin-Kinase Domain of Insulin Receptor (5)
|
BIOTIN-THR-ARG-ASP-ILE-PTYR-GLU-THR-ASP-PTYR-PTYR-ARG-LYS
|
|
|
C. difficile Toxin B (248-262)
|
ASN-GLY-GLU-SER-PHE-ASN-LEU-TYR-GLU-GLN-GLU-LEU-VAL-GLU-ARG
|
|
|
Kinase Domain of Insulin Receptor (1)
|
TYR-GLU-THR-ASP-PTYR-TYR-ARG-LYS-GLY-GLY-LYS-GLY-LEU
|
|
|
H-Met-Gly-Pro-pNA
|
H-MET-GLY-PRO-PNA
|
|
|
Somatostatin-28 (1-12)
|
SER-ALA-ASN-SER-ASN-PRO-ALA-MET-ALA-PRO-ARG-GLU
|
|
|
TNF-α(78-96) (human)
|
H-HIS-THR-ILE-SER-ARG-ILE-ALA-VAL-SER-TYR-GLN-THR-LYS-VAL-ASN-LEU-LEU-SER-ALA-OH
|
|
|
Ac-Gly-Pro-Lys(Ac)-pNA
|
|
|
|
Ac-Ile-Glu-Gly-Arg-pNA
|
|
|
|
Ceratotoxin B
|
CERATOTOXIN B
|
150671-05-9
|
|
C. difficile Toxin B (529-536)
|
ALA-GLN-PHE-GLU-GLU-TYR-LYS-ARG
|
|
|
SRC Kinase Substrate, amide
|
ARG-ARG-LEU-ILE-GLU-ASP-ALA-GLU-PTYR-ALA-ALA-ARG-GLY-NH2
|
|
|
Pyr-Gly-Arg-pNA
|
PYR-GLY-ARG-PNA
|
|
|
Saposin C22
|
CYS-GLU-PHE-LEU-VAL-LYS-GLU-VAL-THR-LYS-LEU-ILE-ASP-ASN-ASN-LYS-THR-GLU-LYS-GLU-ILE-LEU
|
|
|
Boc-Phe-Ala-Ala-Gly-Arg-Lys-AMC
|
BOC-PHE-ALA-ALA-GLY-ARG-LYS-AMC
|
|
|
Boc-Pro-Arg-Arg-AMC
|
BOC-PRO-ARG-ARG-AMC
|
|
|
PKG Substrate
|
GLN-LYS-ARG-PRO-ARG-ARG-LYS-ASP-THR-PRO
|
|
|
Steroid Receptor Co - Factor Peptide
|
LEU-THR-GLU-ARG-HIS-LYS-ILE-LEU-HIS-ARG-LEU-LEU-GLN-GLU
|
|
|
SH2 Domain Ligand (4)
|
AC-TYR(PO3H2)-TYR(PO3H2)-TYR(PO3H2)-ILE-GLU-OH
|
159439-85-7
|
|
Salusin- β
|
H-ALA-ILE-PHE-ILE-PHE-ILE-ARG-TRP-LEU-LEU-LYS-LEU-GLY-HIS-HIS-GLY-ARG-ALA-PRO-PRO-OH
|
|
|
Biotin-Secretin,human
|
BIOTIN-HIS-SER-ASP-GLY-THR-PHE-THR-SER-GLU-LEU-SER-ARG-LEU-ARG-GLU-GLY-ALA-ARG-LEU-GLN-ARG-LEU-LEU-GLN-GLY-LEU-VAL-NH2
|
|
|
Lamprey PQRFamide
|
SER-TRP-GLY-ALA-PRO-ALA-GLU-LYS-PHE-TRP-MET-ARG-ALA-MET-PRO-GLN-ARG-PHE-NH2
|
|
|
R 892
|
AC-LYS-ARG-PRO-PRO-GLY-Α-ME-PHE-SER-D-Β-NAL-ILE-OH
|
229030-05-1
|
|
P55-TNFR
|
LEU-PRO-GLN-ILE-GLU-ASN-VAL-LYS-GLY-THR-GLU-ASP
|
|
|
RF-amide peptide, Drosophila
|
THR-ASP-VAL-ASP-HIS-VAL-PHE-LEU-ARG-PHE-NH2
|
|
|
Caspase 1 Substrate 1 (ICE), chromogenic
|
AC-TYR-GLU-VAL-ASP-PNA
|
|
|
FMRF-related peptide, SDPFLRF-NH2
|
GLY-ASP-PRO-PHE-LEU-ARG-PHE-NH2
|
|
|
pTH (53-84) (human)
|
GLU-ALA-ASP-LYS-ALA-ASP-VAL-ASN-VAL-LEU-THR-LYS-ALA-LYS-SER-GLN: EADKADVNVLTKAKSQ
|
|
|
Kinase Domain of Insulin Receptor (4)
|
THR-ARG-ASP-ILE-TYR-GLU-THR-ASP-TYR-PTYR-ARG-LYS
|
|
|
CC Chemokine Receptor 3 Fragment II
|
MET-THR-THR-SER-LEU-ASP-THR-VAL-GLU-THR-PHE-GLY-THR-THR-SER-TYR-TYR-ASP-ASP-VAL-GLY-LEU-LEU-CYS
|
|
|
Caspase-2 substrate
|
AC-VAL-ASP-VAL-ALA-ASP-PNA
|
189684-53-5
|
|
Neurokinin Receptor (393-407), rat
|
LYS-THR-MET-THR-GLU-SER-SER-PHE-TYR-SER-ASN-MET-LEU-ALA
|
|
|
Insulin Receptor (1142-1153)
|
THR-ARG-ASP-ILE-TYR-GLU-THR-ASP-TYR-TYR-ARG-LYS-NH2
|
|
|
MARCKS PSD-Derived Peptide, PKC Substrate
|
LYS-LYS-ARG-PHE-SER-PHE-LYS-LYS-SER-PHE-LYS-LEU
|
|
|
C. difficile Toxin B (392-401)
|
ASP-SER-TYR-CYS-SER-ASN-LEU-ILE-VAL-LYS
|
|
|
C. difficile Toxin B (232-241)
|
ILE-THR-GLN-ASN-SER-GLY-ASN-ASP-VAL-ARG
|
|
|
Prepro TRH (160-169)
|
SER-PHE-PRO-TRP-MET-GLU-SER-ASP-VAL-THR
|
|
|
Kinase Domain of Insulin Receptor (5)
|
THR-ARG-ASP-ILE-PTYR-GLU-THR-ASP-PTYR-PTYR-ARG-LYS
|
|
|
D-Phe7, D-Trp10]-Somatostatin 14 (7-14)
|
D-PHE-CYS-TYR-D-TRP-LYS-THR-CYS-THR (DISULFIDE BRIDGE: CYS2-CYS7)
|
|
|
Ac-Ile-Glu-Ala-Arg-pNA
|
AC-ILE-GLU-ALA-ARG-PNA
|
|
|
CC Chemokine Receptor 3 Fragment I, amide
|
MET-THR-THR-SER-LEU-ASP-THR-VAL-GLU-THR-PHE-GLY-THR-THR-SER-TYR-TYR-ASP-ASP-VAL-GLY-LEU-LEU-CYS-GLU-LYS-ALA-ASP-THR-ARG-NH2
|
|
|
N(p-Tosyl)-Gly-Pro-Arg-pNA
|
N(P-TOSYL)-GLY-PRO-ARG-PNA
|
|
|
CC Chemokine Receptor 3 Fragment II, amide
|
MET-THR-THR-SER-LEU-ASP-THR-VAL-GLU-THR-PHE-GLY-THR-THR-SER-TYR-TYR-ASP-ASP-VAL-GLY-LEU-LEU-CYS-NH2
|
|
|
C. difficile Toxin B (8-16)
|
GLN-LEU-GLU-LYS-MET-ALA-ASN-VAL-ARG
|
|
|
Kinase Domain of Insulin Receptor (2)
|
THR-ARG-ASP-ILE-PTYR-GLU-THR-ASP-TYR-TYR-ARG-LYS
|
|
|
Boc-Arg-Arg-Arg-AMC
|
BOC-ARG-ARG-ARG-AMC
|
|
|
TNF-α (72-82), human
|
H-PRO-LEU-ALA-GLN-ALA-VAL-ARG-SER-SER-SER-ARG-OH
|
|
|
RSK Substrate, S6 (231-239)
|
ARG-ARG-ARG-LEU-SER-SER-LEU-ARG-ALA-NH2
|
|
|
Ac-Gly-Pro-Lys-pNA
|
AC-GLY-PRO-LYS-PNA
|
|
|
Protein Kinase C Substrate, Glycogen Synthase (1-8)
|
PRO-LEU-SER-ARG-THR-LEU-SER-VAL-ALA-ALA-LYS-LYS-NH2
|
|
|
AT1A, Angiotensin II receptor, (225-237)
|
ALA-TYR-GLU-ILE-GLN-LYS-ASN-LYS-PRO-ARG-ASN-ASP-ASP
|
|
|
Human CMV Assemblin Protease Substrate (M-site)
|
ARG-GLY-VAL-VAL-ASN-ALA-SER-SER-ARG-LEU-ALA-LYS
|
|
|
MMP-3 Substrate I, fluorogenic
|
DNP-PRO-TYR-ALA-TYR-TRP-MET-ARG
|
|
|
Interleukin-6 Receptor (partial)
|
THR-SER-LEU-PRO-VAL-GLN-ASP-SER-SER-SER-VAL-PRO
|
|
|
Suc-Arg-Gly-Pro-Phe-pNA
|
SUC-ARG-GLY-PRO-PHE-PNA
|
|
|
P60c-src Substrate II, Phosphorylated
|
AC-ILE-TYR(PO3H2)-GLY-GLU-PHE-NH2
|
284660-72-6
|
|
Suc-Ser-Asp-Pro-Phe-pNA
|
SUE-SER-ASP-PRO-PHE-PNA
|
|
|
RF-amide, Chicken
|
LEU-PRO-LEU-ARG-PHE-NH2: LPLRF-NH2
|
|
|
Biotin-Kinase Domain of Insulin Receptor (2)
|
BIOTIN-THR-ARG-ASP-ILE-PTYR-GLU-THR-ASP-TYR-TYR-ARG-LYS
|
|
|
C. difficile Toxin B (192-207)
|
ALA-GLN-ARG-GLU-GLU-ASN-PRO-GLU-LEU-ILE-ILE-ASP-ASP-ILE-VAL-LYS
|
|
|
Insulin Receptor (1142-1153), pTyr1150, Biotinylated
|
BIOTIN-THR-ARG-ASP-ILE-TYR-GLU-THR-ASP-PTYR-TYR-ARG-LYS
|
|
|
Angiotensin II Receptor, AT2, Amino Terminal Fragment
|
MET-LYS-ASP-ASN-PHE-SER-PHE-ALA-ALA-THR-SER-ARG-ASN-ILE-THR-SER-SER
|
|
|
MARCKS Substrate (151-175)
|
LYS-LYS-LYS-LYS-LYS-ARG-PHE-PSER-PHE-LYS-LYS-PSER-PHE-LYS-LEU-SER-GLY-PHE-PSER-PHE-LYS-LYS-ASN-LYS-LYS
|
|
|
GSK3 Peptide Substrate
|
GLY-ARG-PRO-ARG-THR-THR-SER-PHE-ALA-GLU
|
|
|
Vanilloid Receptor Subtype 1 (VR1)
|
CYS-GLU-ASP-ALA-GLU-VAL-PHE-LYS-ASP-SER-MET-VAL-PRO-GLY-GLU-LYS
|
|
|
Saposin C18
|
VAL-LYS-GLU-VAL-THR-LYS-LEU-ILE-ASP-ASN-ASN-LYS-THR-GLU-LYS-GLU-ILE-LEU
|
|
|
MMP Biotinylated Substrate I
|
BIOTIN-LC-PRO-LEU-GLY-LEU-ARG-ALA-TYR-NH2
|
|
|
D-Ser13]-Somatostatin-14
|
(D-SER13)-SOMATOSTATIN-14
|
|
|
Tyr12]-Somatostatin-28 (1-14)
|
(TYR12)-SOMATOSTATIN-28 (1-14)
|
|
|
TNF-α(71-82), human
|
H-SER-PRO-LEU-ALA-GLN-ALA-VAL-ARG-SER-SER-SER-ARG-OH
|
|
|
Tyr63] PTH (63-84), human
|
TYR-GLU-LYS-SER-LEU-GLY-GLU-ALA-ASP-LYS-ALA-ASP-VAL-ASN-VAL-LEU-THR-LYS-ALA-LYS-SER-GLN
|
|
|
Angiotensin II type 1 receptor (181-187), AT1, ATE.
|
ALA-PHE-HIS-TYR-GLU-SER-GLN
|
|
|
Biotin-(Leu8,D-Trp22,Tyr25)-Somatostatin-28
|
BIOTIN-SER-ALA-ASN-SER-ASN-PRO-ALA-LEU-ALA-PRO-ARG-GLU-ARG-LYS-ALA-GLY-CYS-LYS-ASN-PHE-PHE-D-TRP-LYS-THR-TYR-THR-SER-CYS (DISULFIDE BRIDGE:CYS17-CYS28)
|
|
|
SRC Kinase Substrate
|
ARG-ARG-LEU-ILE-GLU-ASP-ALA-GLU-PTYR-ALA-ALA-ARG-GLY
|
|
|
SH2 Domain Ligand (3)
|
BIOTIN-LC-GLU-PRO-GLN-PTYR-GLU-GLU-ILE-PRO-ILE-TYR-LEU
|
|
|
PDGF β-Receptor (739-746) (phosphorylated)
|
TYR(PO3H2)-MET-ALA-PRO-TYR-ASP-ASN-TYR
|
|
|
Secretin-Lys(Biotin), human
|
HIS-SER-ASP-GLY-THR-PHE-THR-SER-GLU-LEU-SER-ARG-LEU-ARG-GLU-GLY-ALA-ARG-LEU-GLN-ARG-LEU-LEU-GLN-GLY-LEU-VAL-LYS(BIOTIN)
|
|
|
Somatostatin-14 (3-14)
|
CYS-LYS-ASN-PHE-PHE-TRP-LYS-THR-PHE-THR-SER-CYS (DISULFIDE BRIDGE:CYS1-CYS12)
|
54518-51-3
|
|
Biotin-RR-SRC, Insulin Receptor Tyrosine Kinase Substrate
|
BIOTIN-ARG-ARG-LEU-ILE-GLU-ASP-ALA-GLU-TYR-ALA-ALA-ARG-GLY-OH
|
|
|
Somatostatin-14 (2-9)
|
GLY-CYS-LYS-ASN-PHE-PHE-TRP-LYS
|
|
|
Casein Kinase II Receptor Peptide
|
ARG-ARG-GLU-GLU-GLU-THR-GLU-GLU-GLU
|
198481-81-1
|
|
Caspase 3 Substrate, chromogenic
|
AC-VAL-GLN-VAL-ASP-PNA
|
|
|
Caspase 2 Substrate 1m (ICH-1), fluorogenic
|
AC-VAL-ASP-VAL-ALA-ASP-AMC
|
|
|
Somatostatin Tumor Inhibiting Analog
|
D-Β-NAL-CYS-TYR-D-TRP-LYS-VAL-CYS-THR-NH2 (DISULFIDE BRIDGE:CYS2-CYS7 )
|
|
|
Suc-Ala-Pro-Ala-pNA
|
SUC-ALA-PRO-ALA-PNA
|
72682-79-2
|
|
P75-TNFR Fragment
|
SER-MET-ALA-PRO-GLY-ALA-VAL-HIS-LEU-PRO-GLN-PRO
|
|
|
Suc-Leu-Glu-Pro-Phe-pNA
|
SUC-LEU-GLU-PRO-PHE-PNA
|
|
|
P60c-src Substrate II
|
AC-ILE-TYR-GLY-GLU-PHE-NH2
|
168781-78-0
|
|
Kinase Domain of Insulin Receptor (3)
|
THR-ARG-ASP-ILE-TYR-GLU-THR-ASP-PTYR-TYR-ARG-LYS
|
|
|
Leptin Receptor Precursor
|
PRO-PHE-VAL-LYS-PTYR-ALA-THR-LEU-ILE-SER-ASN
|
|
|
Biotin-LC-Protein Kinase G Substrate; Biotin-LC-G-Subtide
|
BIOTIN-LC-GLN-LYS-ARG-PRO-ARG-ARG-LYS-ASP-THR-PRO
|
|
|
Transglutaminase Substrate, biotinylated
|
BIOTIN-THR-VAL-GLN-GLN-GLU-LEU
|
|
|
Saposin C12
|
LEU-ILE-ASP-ASN-ASN-LYS-THR-GLU-LYS-GLU-ILE-LEU
|
|
|
Biotin-Insulin Receptor (1142-1153), amide
|
BIOTIN-THR-ARG-ASP-ILE-TYR-GLU-THR-ASP-TYR-TYR-ARG-LYS-NH2
|
|
|
PGC-1α (205-216), Proliferator-activated Receptor Coactivator-1 α (205-216)
|
PGC - 1ALFA (205–216), PROLIFERATOR – ACTIVATED RECEPTOR COACTIVATOR - 1 ALFA (205–216)
|
|
|
Des-Ala1,des-Gly2,His4,5,D-Trp8]-Somatostatin-14
|
(DES-ALA1,DES-GLY2,HIS4·5,D-TRP8)-SOMATOSTATIN-14
|
|
|
Casein Kinase II Substrate
|
ARG-ARG-ARG-GLU-GLU-GLU-THR-GLU-GLU-GLU: RRREEETEEE
|
|
|
MMP-1 Substrate I, fluorogenic
|
DNP-PRO-LEU-ALA-LEU-TRP-ALA-ARGDNP-PRO-LEU-GLY-MET-TRP-SER-ARGCYS-THR-THR-HIS-TRP-GLY-PHE-THR-LEU-CYS
|
135662-04-3
|
|
Hepatitis B Virus Receptor Binding Fragment
|
PRO-LEU-GLY-PHE-PHE-PRO-ASP-HIS-GLN-LEU-ASP-PRO-ALA-PHE-GLY-ALA-ASN-SER-ASN-ASN-PRO-ASP-TRP-ASP-PHE-ASN-PRO
|
|